Patents (1436 Stem Cell Patents)

Class: Differentiation (190)

Order by:
<< | < | 4 5 6 7 8 9 10 11 12 | > | >>


Hepatocyte lineage cells derived from pluripotent stem cells

Patent Number: 6506574

This patent teaches how to generate hepatocytes by the differentiation of embryonic stem cells. Methods of using the newly generated hepatocytes for drug screening are also provided. The patent describes uses of histone decetylase inhibitors in the culture and differentiation process.

Inventors: Rambhatla, Lakshmi (Redwood City, CA); Carpenter, Melissa K. (Castro Valley, CA)
Assignee: Geron Corporation (Menlo Park, CA)
Date of First Priority Issue: Thursday April 27th, 2000

Hepatocyte lineage cells derived from pluripotent stem cells

Patent Number: 6458589

This patent covers methods of generating and isolating hepatocytes from embryonic stem cells. The hepatocytes are designated by specific phenotypic and functional characteristics that are described in the patent. This invention could be useful for treatment of a wide variety of disorders ranging from hepatitis to cirrhosis.

Inventors: Rambhatla, Lakshmi (Redwood City, CA); Carpenter, Melissa K. (Castro Valley, CA)
Assignee: geron
Date of First Priority Issue: Thursday April 27th, 2000

Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

Patent Number: 6774120

This patent teaches how to make liver cells behave like pancreatic cells and even offers the possibility of treating type 1 diabetes. Essentially the patent claims that by transfecting liver cells with the pancreatic stem cell transcription factor PDX-1, the liver cells will start producing insulin (besides other things).

Inventor: Ferber, Sarah (Ramat Hasharon, IL)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Wednesday April 19th, 2000

Therapeutic uses for mesenchymal stromal cells

Patent Number: 6673606

This patent teaches how to induce the differentiation of mesenchymal stem cells into oligodendrocyte cells. These oligodendrocytes may be used for treatment of various metabolic and nervous system disorders.

Inventors: Tennekoon, Gihan (Wynnewood, PA); Coyle, Andrew J. (Philadelphia, PA); Grinspan, Judith (Ardmore, PA); Beesley, Jackie S. (West Sussex, GB)
Assignee: The Children's Hospital of Philadelphia (Philadelphia, PA
Date of First Priority Issue: Wednesday April 12th, 2000

Embryonic stem cells and neural progenitor cells derived therefrom

Patent Number: 7,504,257

This patent covers methods of generating neural progenitor cells from embryonic stem cells in vitro.  In its one issued claim the inventors teach the administration of EGF and FGF-2 to serum-free media containing undifferentiated pluripotent human embryonic stem cells in order to give rise to tripotent neural progenitor cells.  The neural progenitor cells are capable of...

Inventors: Reubinoff; Benjamin Eithan (Mevaseret-Zion, IL), Pera; Martin Frederick (Prahran, AU), Ben-Hur; Tamir (Ramat Sharet, IL)
Assignee: ES Cell International PTE Ltd. (Singapore, SG)
Date of First Priority Issue: Tuesday March 14th, 2000

Method of making embryoid bodies from primate embryonic stem cells

Patent Number: 6602711

This is a patent for forming what is called "embryoid bodies" which are cellular aggregated generated from embryonic stem cells. Embryoid bodies can be subsequently dissociated in order to form various histological tissues useful for regenerative purposes.

Inventors: Thomson, James A (Madison, WI); Marshall, Vivienne S. (Madison, WI); Swiergiel, Jennifer J. (Roscoe, IL)
Assignee: Wisconsin Alumni Research Foundation (Madison, WI)
Date of First Priority Issue: Monday February 21st, 2000

Differentiation of bone marrow cells into neuronal cells and uses therefor

Patent Number: 7,279,331

This patent covers the differentiation of bone marrow stromal stem cells into neurons through the addition of antioxidants. The patent is limited to in vitro differentiation. Specific antioxidants that the inventors cover for the in vitro generation of neurons include beta-mercaptoethanol, dimethylsulfoxide, butylated hydroxytoluene, butylated hydroxyanisole, ascorbic acid...

Inventors: Black; Ira B. (Skillman, NJ), Woodbury; Dale L. (Piscataway, NJ), Prockop; Darwin J. (New Orleans, LA), Schwarz; Emily (Chapel Hill, NC)
Assignee: Philadelphia Health and Education Corporation (Philadelphia, PA)
Date of First Priority Issue: Friday February 11th, 2000

Erythrocytic cells and method for preserving cells

Patent Number: 6770478

This patent covers methods of preserving red blood cells through cryopreservation. The method involves depletion of cholesterol and loading of the cells with an oligosaccharide. Cryopreservation according to this method may be performed in stem cell derived erythrocytes for use in emergency situations.

Inventors: Crowe, John H. (Davis, CA); Crowe, Lois M. (Davis, CA); Tablin, Fern (Davis, CA); Wolkers, Willem F (Davis, CA); Tsvetkova, Nelly M. (Davis, CA); Oliver, Ann F. (Davis, CA)
Assignee: The Regents of the University of California (Oakland, CA)
Date of First Priority Issue: Thursday February 10th, 2000

Progenitor cells and methods and uses related thereto

Patent Number: 6610535

This patent teaches the generation of islet like cells from pancreatic stem cells. It is useful for the treatment of diabetes. One source of stem cells used in this patent is pancreatic duct stem cells.

Inventors: Lu, Kuanghui (Brookline, MA); Pang, Kevin (Canton, MA); Rubin, Lee (Wellesley, MA)
Assignee: ES Cell International Pte Ltd. (SG)
Date of First Priority Issue: Thursday February 10th, 2000

Directed differentiation of human embryonic cells

Patent Number: 7045353

This is basically the patent that covers how to generate neurons from embryonic stem cells. Of course the various composition of matter patents on embryonic stem cells (5,843,780, 6,200,806, 7,029,913) have to be in-licensed to use this invention. The invention has one broad independent claim which covers a method of differentiating human embryonic stem cells into neurons. The method...

Inventor: Benvenisty, Nissim (Jerusalem, IL)
Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem (Jerusalem, IL)
Date of First Priority Issue: Saturday January 8th, 2000

Order by:
<< | < | 4 5 6 7 8 9 10 11 12 | > | >>

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent